The regulatory affairs functions may risk becoming disconnected from organizations if they only get involved with issues after they have been completed by other departments. This can lead to misunderstandings and create a perception that the regulatory group is always opposing new initiatives, which can be difficult to overcome.
In order to have a greater impact, it is important to organize the government affairs function effectively, as outlined in a report by McKinsey & Co.
A regulatory affairs manager is responsible for developing strategies to ensure compliance with regulations, implementing training programs to educate employees on policies and standards, conducting internal inspections and awareness campaigns, and staying up to date with the latest rules and regulations.
Regulatory affairs shares many similarities with project management, as both require the careful coordination and planning of various components to achieve specific outcomes. This is particularly evident during the development and introduction of new products and services, highlighting the importance of skills such as project management in regulatory affairs.
A regulatory specialist plays a crucial role in this field, being responsible for specific tasks and responsibilities.
Regulatory strategy involves addressing developmental issues, planning for regulatory affairs, registering products in the global market, and effectively managing cost, time, and resources.
In conclusion, regulatory affairs is a critical and essential component of every pharmaceutical business. It requires a combination of hard and soft skills and necessitates ongoing professional development.
The strategic importance and role of regulatory affairs and regulatory affairs strategy cannot be overstated.
The decision-making process in Regulatory Affairs is not as straightforward as the definition suggests.
Instead of trying to control, Regulatory Affairs should aim to guide.
Setting meaningful Key Performance Indicators (KPIs) for Regulatory Affairs (RA) in the pharmaceutical industry is a complex task. It can be difficult to measure the long-term value of a submission and ensure that the chosen regulatory strategy aligns with the agencies' long-term trends.
The Regulatory Performance Framework KPI Measures focuses on ensuring that regulators do not unduly hinder the efficient functioning of regulated entities.
KPI 1, specifically, examines the extent to which regulators impede the efficient operation of these entities. To assess this, the KPI1 table includes a list of regulators that may hinder efficiency. The table consists of two columns, one being the Regulatory Performance Framework KPI Measures.
One measure of good regulatory performance is an demonstrated understanding of the operating environment of regulated entities.
Another potential measure is evidence of engagement with industry and industry associations, such as through strategic consultative committees and attendance at industry meetings and forums.
These measures are part of the Regulatory Performance Framework KPI Measures used by the Department of Health.